| Triggering a cell shape change by exploiting preexisting actomyosin contractions. Roh-Johnson M., Shemer G., Higgins C.D., McClellan J.H., Werts A.D., Tulu U.S., Gao L., Betzig E., Kiehart D.P., Goldstein B.
Science 335:1232-1235(2012) · Mapped (1) |
| The chemokine receptor CCR2 is not required for successful initiation of labor in mice. Menzies F.M., Khan A.H., Higgins C.A., Nelson S.M., Nibbs R.J.
Biol. Reprod. 86:118-118(2012) · Mapped (4) |
| Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation. Cesa L.C., Higgins C.A., Sando S.R., Kuo D.W., Levandoski M.M.
Mol. Pharmacol. 81:239-249(2012) · Mapped (2) |
| Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Jain R., von Hurst P.R., Stonehouse W., Love D.R., Higgins C.M., Coad J.
Metab. Clin. Exp. 61:293-301(2012) · Mapped (6) |
| Redox-induced Src kinase and caveolin-1 signaling in TGF-beta1-initiated SMAD2/3 activation and PAI-1 expression. Samarakoon R., Chitnis S.S., Higgins S.P., Higgins C.E., Krepinsky J.C., Higgins P.J.
PLoS ONE 6:e22896-e22896(2011) · Mapped (12) |
| Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates. Schaap-Nutt A., Higgins C., Amaro-Carambot E., Nolan S.M., D'Angelo C., Murphy B.R., Collins P.L., Schmidt A.C.
J. Virol. 85:4007-4019(2011) · Mapped (2) |
| The N-terminal peptide of mammalian GTP cyclohydrolase I is an autoinhibitory control element and contributes to binding the allosteric regulatory protein GFRP. Higgins C.E., Gross S.S.
J. Biol. Chem. 286:11919-11928(2011) · Mapped (1) |
| Asymmetric cell division: a new way to divide unequally. Higgins C.D., Goldstein B.
Curr. Biol. 20:R1029-31(2010) · Mapped (2) |
| Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Schaap-Nutt A., D'Angelo C., Amaro-Carambot E., Nolan S.M., Davis S., Wise S.M., Higgins C., Bradley K., Kim O., Mayor R. et al.
Virology 406:65-79(2010) · Mapped (1) |
| Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Lobo C., Lopes G., Baez O., Castrellon A., Ferrell A., Higgins C., Hurley E., Hurley J., Reis I., Richman S. et al.
Breast Cancer Res. Treat. 123:427-435(2010) · Mapped (8) |
| PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes. Freytag J., Wilkins-Port C.E., Higgins C.E., Higgins S.P., Samarakoon R., Higgins P.J.
J. Invest. Dermatol. 130:2179-2190(2010) · Mapped (32) |
| Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Jelic S., Padeletti M., Kawut S.M., Higgins C., Canfield S.M., Onat D., Colombo P.C., Basner R.C., Factor P., LeJemtel T.H.
Circulation 117:2270-2278(2008) · Mapped (8) |
| SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Providence K.M., Higgins S.P., Mullen A., Battista A., Samarakoon R., Higgins C.E., Wilkins-Port C.E., Higgins P.J.
Arch. Dermatol. Res. 300:303-310(2008) · Mapped (4) |
| TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. Samarakoon R., Higgins S.P., Higgins C.E., Higgins P.J.
J. Mol. Cell. Cardiol. 44:527-538(2008) · Mapped (23) |
| Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. Taylor S.R., Gonzalez-Begne M., Dewhurst S., Chimini G., Higgins C.F., Melvin J.E., Elliott J.I.
J. Immunol. 180:300-308(2008) · Mapped (17) |
| Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer. Raguz S., Randle R.A., Sharpe E.R., Foekens J.A., Sieuwerts A.M., Meijer-van Gelder M.E., Melo J.V., Higgins C.F., Yague E.
Int. J. Cancer 122:1058-1067(2008) · UniProtKB (1) · Mapped (8) |
| HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. McAulay K.A., Higgins C.D., Macsween K.F., Lake A., Jarrett R.F., Robertson F.L., Williams H., Crawford D.H.
J. Clin. Invest. 117:3042-3048(2007) · Mapped (727) |
| SERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition "wound repair" transcriptome in p53 mutant human keratinocytes. Qi L., Higgins S.P., Lu Q., Samarakoon R., Wilkins-Port C.E., Ye Q., Higgins C.E., Staiano-Coico L., Higgins P.J.
J. Invest. Dermatol. 128:749-753(2008) · Mapped (4) |
| Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning. Pownall H.J., Hosken B.D., Gillard B.K., Higgins C.L., Lin H.Y., Massey J.B.
Biochemistry 46:7449-7459(2007) · Mapped (4) |
| Regulatory T cells are resistant to apoptosis via TCR but not P2X7. Taylor S.R., Alexander D.R., Cooper J.C., Higgins C.F., Elliott J.I.
J. Immunol. 178:3474-3482(2007) · Mapped (17) |
| The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus. Okkenhaug H., Weylandt K.H., Carmena D., Wells D.J., Higgins C.F., Sardini A.
FASEB J. 20:2390-2392(2006) · Mapped (5) |
| The C. elegans gene dig-1 encodes a giant member of the immunoglobulin superfamily that promotes fasciculation of neuronal processes. Burket C.T., Higgins C.E., Hull L.C., Berninsone P.M., Ryder E.F.
Dev. Biol. 299:193-205(2006) · Mapped (2) |
| Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Elliott J.I., Surprenant A., Marelli-Berg F.M., Cooper J.C., Cassady-Cain R.L., Wooding C., Linton K., Alexander D.R., Higgins C.F.
Nat. Cell Biol. 7:808-816(2005) · Mapped (7) |
| Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis. Raguz S., De Bella M.T., Slade M.J., Higgins C.F., Coombes R.C., Yague E.
Int. J. Cancer 117:934-941(2005) · UniProtKB (1) · Mapped (3) |
| The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products. Elliott J.I., McVey J.H., Higgins C.F.
Arthritis Res. Ther. 7:R468-75(2005) · Mapped (11) |
